Biond Biologics and Sanofi Enter into Global Licensing Agreement Worth $1 Billion
Tehila Ben-Moshe co-founder and CEO Israeli biopharmaceutical company Biond Biologics which developing novel immunotherapies for cancer has entered into an exclusive worldwide license agreement with Sanofi, More...
Resignation of Alfred Mann Helps Lift Mannkind Stock 22%
Following the resignation of Alfred Mann as CEO and the announcement of a large payment from partner Sanofi, and ahead of the launch of a new diabetes medication, shares of biopharmaceutical company MannKind More...
4 Fast Money Picks for Thursday: Home Depot, HYG, Merck, Amgen
The traders on CNBC’s Fast Money discussed picks for Thursday, October 23, 2014. Dan Nathan would sell Home Depot. The company has been facing headwinds lately, including a security breach that might More...
Billionaire Alfred Mann Dedicated to Mankind
Alfred Mann, physicist, inventor and founder of biotech company Mannkind has one focus–Mankind. At the age of 88, Mann still works 70 hour weeks, and is on a quest of a lifetime to eradicate as More...
Jim Cramer on 2 Negative Stories Turned Positive: Mannkind and Tesla
– Jim Cramer discussed two negative stock stories that have turned positive. Tesla (TSLA) has been a “cult stock” that Cramer has been leery about, but an upgrade from Deutsche Bank points More...
International Cosmetic Giant L’Oréal Reports Record $4.3 Billion 2013 Net Profit
– Earlier today, L’Oréal, the international cosmetics and beauty products giant, announced its financial results for its full 2013 fiscal year, and delivered up another excellent year’s More...